These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 23513918)
1. [Prediction of efficacy of molecular targeted agents for rheumatoid arthritis]. Izumi K; Kameda H Nihon Rinsho; 2012 Nov; 70 Suppl 8():658-63. PubMed ID: 23513918 [No Abstract] [Full Text] [Related]
2. TNF-alpha antagonists and other recombinant proteins for the treatment of rheumatoid arthritis. Brasington R J Hand Surg Am; 2009 Feb; 34(2):349-50. PubMed ID: 19135810 [No Abstract] [Full Text] [Related]
3. [Biological agents for therapy of rheumatoid arthritis--overview]. Takeuchi T Nihon Rinsho; 2005 Jan; 63 Suppl 1():513-6. PubMed ID: 15799409 [No Abstract] [Full Text] [Related]
4. Abatacept: new drug. Rheumatoid arthritis: after failure of TNF alpha antagonists and rituximab. Prescrire Int; 2008 Dec; 17(98):232. PubMed ID: 19422143 [No Abstract] [Full Text] [Related]
10. Do we need new treatment that goes beyond tumor necrosis factor blockers for rheumatoid arthritis? Voll RE; Kalden JR Ann N Y Acad Sci; 2005 Jun; 1051():799-810. PubMed ID: 16127017 [TBL] [Abstract][Full Text] [Related]
11. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents. Finckh A; Ciurea A; Brulhart L; Kyburz D; Möller B; Dehler S; Revaz S; Dudler J; Gabay C; Arthritis Rheum; 2007 May; 56(5):1417-23. PubMed ID: 17469098 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists. Isaacs JD Expert Opin Biol Ther; 2009 Dec; 9(12):1463-75. PubMed ID: 19916731 [TBL] [Abstract][Full Text] [Related]